Taliban to Resume Afghanistan’s House-to-House Polio Vaccination Campaign 19/10/2021 Raisa Santos The World Health Organization and UNICEF welcome the decision made by Taliban to support the resumption of house-to-house polio vaccination across Afghanistan. The vaccination campaign, which begins 8 November, will be the first in over three years to reach all children in Afghanistan, including more than 3.3 million children in some parts of the country […] Continue reading -> Medecins Sans Frontieres: 870m Vaccine Doses Being Hoarded by 10 Rich Countries – ‘Tragedy’ for Those Deprived of Jabs 08/10/2021 Madeleine Hoecklin The hoarding of more than 870 million excess doses of COVID-19 vaccines in just 10 high-income countries is likely to deprive hundreds of millions of healthcare workers and vulnerable populations in low- and middle-income countries of the opportunity to get even a first vaccine dose, according to a new report by Medecins Sans Frontieres (MSF). […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> ‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Medecins Sans Frontieres: 870m Vaccine Doses Being Hoarded by 10 Rich Countries – ‘Tragedy’ for Those Deprived of Jabs 08/10/2021 Madeleine Hoecklin The hoarding of more than 870 million excess doses of COVID-19 vaccines in just 10 high-income countries is likely to deprive hundreds of millions of healthcare workers and vulnerable populations in low- and middle-income countries of the opportunity to get even a first vaccine dose, according to a new report by Medecins Sans Frontieres (MSF). […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> ‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> ‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Constructive Tone’ Now Emerging Among World Trade Organization Members On IP Waiver for COVID Health Products 07/10/2021 Elaine Ruth Fletcher Discussions over a controversial World Trade Organization waiver on intellectual property related to COVID vaccines, treatments and other tools, have become more “constructive” said a senior WTO spokesman on Thursday, in a press briefing on the first day of the WTO’s two-day General Council meeting. There has been a “subtle shifting in the direction of […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts